Our mission is to treat devastating diseases with intracellular therapeutics

Dipal Doshi Thumbnail V3

"At Entrada, we value intellectual curiosity and enjoy the challenge of fighting the good fight: waking up each day to advance our science one step closer to helping patients and their caregivers who deserve better treatments."

Dipal Doshi,   President and Chief Executive Officer

Novel Platform, Growing Intracellular Therapeutics Pipeline

Our proprietary Endosomal Escape Vehicle (EEV™) Platform is highly versatile and modular, designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index.

Our novel approach is designed to address challenges associated with current therapeutics and engage targets previously considered inaccessible and undruggable. Explore our platform and discover our pipeline.

Our Commitment to Each Other and to You

Social Responsibility V2

At Entrada our approach to corporate social responsibility is built upon our collective commitment to prioritize programs that provide public benefit, advance medical treatments and improve patient outcomes. We are driven to discover, develop and commercialize life-changing medicines that are safe, effective and accessible to those who need them.

We understand that different experiences and perspectives fuel innovation and we are fostering a culture and workplace environment where everyone's voice is heard, and every individual belongs. Our collective success relies on it.

Creating an organization where diversity flourishes and our employees can belong takes ongoing attention and effort – and we know we can’t do it alone. We are proud to actively partner with organizations across Boston, Cambridge and the biotech sector that provide community and mentorship while challenging the status quo so that we can learn, grow and improve the future for all.